For millions of people living with spinal cord injuries, the simple act of standing up and taking a step has long been considered impossible. Traditional medical wisdom held that once the connection between the brain and the lower body was severed, recovery of voluntary movement was permanent and irreversible. That assumption is now being challenged by a pioneering clinical effort in Shanghai, where Chinese researchers have used a new generation of brain-spine interface technology to restore leg movement in paralyzed patients within hours of surgery and enable them to walk with support within weeks.
In early 2025, a team led by scientists at Fudan University’s Institute of Science and Technology for Brain-Inspired Intelligence, working with clinicians at Zhongshan Hospital and Huashan Hospital, completed a series of proof-of-concept surgeries that produced remarkable results. Four patients with severe spinal cord injuries, including complete paraplegia, regained voluntary control of their legs shortly after receiving implants. One of the most closely followed cases involved a man in his thirties, identified in reports as Lin, who had been paralyzed for two years after falling from a staircase. Within 24 hours of his January 2025 operation, he was able to lift both legs. Two weeks later, he was stepping over obstacles and walking more than five meters with the assistance of a standing frame.
The technology at the heart of these procedures is known as a brain-spine interface, or BSI. Unlike conventional brain-computer interfaces that primarily decode neural signals to control external devices such as robotic arms or computer cursors, this system creates an internal “neural bypass.” Tiny electrode chips, each roughly one millimeter in diameter, are implanted in the motor cortex of the brain. These chips detect the patient’s intention to move. An advanced algorithm then decodes the signals in real time and transmits precise electrical stimulation to a second implant placed on the spinal cord below the site of injury. The stimulation reactivates dormant nerve pathways and muscles that had been cut off from brain commands.
Researchers describe the approach as a “triple-integrated” system that combines brain signal acquisition, artificial intelligence decoding, and targeted spinal stimulation into a single, coordinated platform. The surgeries themselves are designed to be minimally invasive. Both the brain and spinal components can be implanted in a single session lasting approximately four hours, significantly reducing the trauma and infection risk associated with earlier methods. By comparison, a high-profile 2023 Swiss study that demonstrated similar principles required more invasive dual craniotomies and staged procedures spread over an extended period.
What distinguishes the Chinese work is not only the speed of functional recovery but also early signs of neural remodeling. Patients reported returning sensations such as warmth, tingling, and muscle contractions in their legs. Some regained awareness of the need to use the toilet, suggesting that deeper sensory and autonomic pathways were beginning to reawaken. Lead researcher Jia Fumin has emphasized that the goal extends beyond temporary electronic assistance. With intensive rehabilitation, the team hopes the nervous system can gradually rewire itself, potentially reducing or even eliminating long-term dependence on the implants.
The scale of the problem the technology seeks to address is substantial. China alone is estimated to have approximately 3.74 million people living with spinal cord injuries, with around 90,000 new cases each year. Globally, the figure exceeds 20 million. For decades, treatment has centered on physical therapy, bracing, and wheelchair mobility, with limited options for restoring voluntary walking. High-profile brain-computer interface projects, including those pursued by companies such as Neuralink, have focused largely on enabling control of external devices under the assumption that the paralyzed limbs themselves cannot recover meaningful function. The Shanghai team’s results challenge that premise by attempting to reconnect the brain to the body’s own neural circuitry.
Patient experiences have been dramatic. Lin, who had spent two years confined to a wheelchair and described daily emotional distress, expressed profound gratitude after regaining the ability to walk short distances. Other patients in the initial cohort similarly demonstrated voluntary leg lifts within a day of surgery and progressive improvements in the following weeks. These outcomes were achieved without the need for external robotic exoskeletons during the early recovery phase, though supportive frames were used for safety and balance training.
Despite the encouraging early data, significant challenges remain. Decoding complex, multi-joint movements in real time continues to be technically demanding. The availability of specialized implantable electrodes is still limited. Patients must commit to intensive daily rehabilitation, often several hours long, to maximize gains. Long-term durability of the implants, risk of device failure, and the sustainability of neural recovery without continuous stimulation all require further study. The current trials have been limited to adults capable of rigorous post-operative training, and broader clinical application will depend on regulatory approval, larger patient cohorts, and refined algorithms.
The research team has indicated plans to expand clinical proof-of-concept studies across additional hospitals, gather more real-world data, and improve the decoding software. Future directions include wearable neuroregulation devices for milder injuries and multi-modal systems capable of monitoring a wider range of movements. Jia has described the work as moving China from a position of primarily adapting foreign high-end medical technology into original innovation in an uncharted domain.
The broader scientific context is important. Earlier animal studies and limited human trials had shown that epidural electrical stimulation of the spinal cord could elicit rhythmic stepping patterns. Combining that approach with direct brain signal decoding represents a logical next step, one that several international groups have pursued. The Chinese results stand out for the rapidity of recovery, the relative minimal invasiveness of the surgical technique, and the early evidence of sensory restoration alongside motor gains. Whether these benefits will prove durable over years rather than months remains an open question that only longer follow-up can answer.
For patients and families affected by spinal cord injury, the psychological impact of even limited restored mobility can be profound. The ability to stand, take steps, and regain some sensation offers more than physical function; it restores a measure of agency and hope that many had been told was permanently lost. At the same time, realistic expectations are essential. Walking with a supportive frame for short distances is not the same as independent community ambulation, and not every patient will achieve the same degree of recovery.
As the technology advances, ethical and practical questions will intensify. Access and cost will determine whether breakthroughs remain confined to specialized centers or become more widely available. The intensive rehabilitation required may create disparities between patients who can commit the necessary time and resources and those who cannot. Regulatory pathways for combination devices that include both implantable hardware and adaptive AI software are still evolving in many countries.
The Shanghai cases mark an important milestone rather than a finished solution. They demonstrate that the barrier between brain intention and paralyzed limbs can be bridged more effectively and less invasively than previously shown in human patients. They also suggest that the nervous system retains a greater capacity for reorganization than many clinicians once believed. Continued careful research, transparent reporting of both successes and limitations, and rigorous long-term monitoring will determine how far this approach can ultimately go.
In the meantime, the images and videos circulating of patients taking their first steps after years of paralysis have captured public attention for good reason. They represent a tangible shift in what is considered medically possible. For the individuals involved, those steps are already life-changing. For the field of neurorehabilitation, they open a new chapter in the effort to restore mobility after spinal cord injury—one that prioritizes reconnecting the body’s own pathways rather than permanently outsourcing movement to machines.
About The Author
